COHERUS BIOSCIENCES I
0,8200
07-ноября-24 14:59:58
15 мин. задержка
Акции
+0,0962
+13,29%
Сегодняшний диапазон
0,7610 - 0,9550
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Coherus Prices Public Offering of Common Stock
16 май 2023 05:50:00 Источник Nasdaq GlobeNewswire
-
Coherus Announces Proposed Public Offering of Common Stock
15 май 2023 15:01:00 Источник Nasdaq GlobeNewswire
-
Coherus BioSciences Reports First Quarter 2023 Financial Results and Business Highlights
08 май 2023 15:05:02 Источник Nasdaq GlobeNewswire
-
Coherus BioSciences to Present at Upcoming Investor Conferences in May
04 май 2023 15:30:00 Источник Nasdaq GlobeNewswire
-
Coherus BioSciences to Report First Quarter 2023 Financial Results on May 8, 2023
01 май 2023 15:07:00 Источник Nasdaq GlobeNewswire
-
27 апр 2023 07:05:00 Источник Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Fourth Quarter and Full Year 2022 Results
06 мар 2023 15:01:00 Источник Nasdaq GlobeNewswire
-
FDA Approves UDENYCA® Autoinjector
06 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Coherus BioSciences to Present at Upcoming Investor Conferences in March
01 мар 2023 07:25:00 Источник Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
28 фев 2023 07:25:00 Источник Nasdaq GlobeNewswire
-
13 фев 2023 07:25:00 Источник Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
03 фев 2023 16:30:09 Источник Nasdaq GlobeNewswire
-
09 янв 2023 07:20:00 Источник Nasdaq GlobeNewswire
-
Coherus BioSciences Management to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 янв 2023 06:01:00 Источник Nasdaq GlobeNewswire
-
23 дек 2022 23:01:00 Источник Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Third Quarter 2022 Results and Provides Business Update
08 ноя 2022 15:01:00 Источник Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Third Quarter 2022 Financial Results on November 8th, 2022
01 ноя 2022 06:30:00 Источник Nasdaq GlobeNewswire
-
12 окт 2022 06:30:00 Источник Nasdaq GlobeNewswire
-
Coherus to Launch CIMERLI™ (ranibizumab-eqrn) in the United States on October 3, 2022
19 сен 2022 06:30:00 Источник Nasdaq GlobeNewswire